ResearcherHarvard UniversityNo recent work listed
Deborah Schrag
Matched on ORCID iD 0000-0002-4334-5717; OpenAlex author ID A5088893766. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2012: 1 paper · 2013: none · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper
Papers 9
- Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma. Co-author DOI 10.1001/jamaoncol.2021.5407↗
- Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis. Co-author DOI 10.1634/theoncologist.2018-0114↗
- Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Co-author DOI 10.1002/cam4.1277↗
- Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer. Co-author DOI 10.1634/theoncologist.2016-0447↗
- Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancer. Co-author DOI 10.1080/01621459.2016.1164052↗
- Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic Cancer Diagnosis. Co-author DOI 10.1111/rssc.12078↗
- National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010. First author DOI 10.1002/cncr.28537↗
- Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. Co-author DOI 10.1634/theoncologist.2014-0086↗
- Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the… Last author DOI 10.1016/j.jpainsymman.2011.09.001↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Brian Matthew Wolpin · 3 shared papers, 2014–2022 · strength 0.30
- Paper Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenoc… DOI 10.1001/jamaoncol.2021.5407↗
- Paper Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer. DOI 10.1634/theoncologist.2016-0447↗
- Paper Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancrea… DOI 10.1634/theoncologist.2014-0086↗
- Francesca Dominici · 3 shared papers, 2014–2016 · strength 0.22
- Paper Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancer. DOI 10.1080/01621459.2016.1164052↗
- Paper Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic C… DOI 10.1111/rssc.12078↗
- Paper National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010. DOI 10.1002/cncr.28537↗
- Winta Tsegay Mehtsun · 1 shared paper, 2022 · strength 0.19
- Jiping Wang · 1 shared paper, 2022 · strength 0.19
- Chung Yin Kong · 2 shared papers, 2018–2019 · strength 0.17
- Angela C. Tramontano · 2 shared papers, 2018–2019 · strength 0.17
- Pari V. Pandharipande · 2 shared papers, 2018–2019 · strength 0.17
- Chin Hur · 2 shared papers, 2018–2019 · strength 0.17
- Ryan David Nipp · 2 shared papers, 2018–2019 · strength 0.17
- Kyu Ha Lee · 2 shared papers, 2015–2016 · strength 0.16
- Paper Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancer. DOI 10.1080/01621459.2016.1164052↗
- Paper Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic C… DOI 10.1111/rssc.12078↗
- Sebastien Haneuse · 2 shared papers, 2015–2016 · strength 0.16
- Paper Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancer. DOI 10.1080/01621459.2016.1164052↗
- Paper Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic C… DOI 10.1111/rssc.12078↗
- Charles S. Fuchs · 2 shared papers, 2014–2017 · strength 0.12
- Paper Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer. DOI 10.1634/theoncologist.2016-0447↗
- Paper Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancrea… DOI 10.1634/theoncologist.2014-0086↗
- Thomas Adam Abrams · 1 shared paper, 2017 · strength 0.08
- Theodore Sunki Hong · 1 shared paper, 2019 · strength 0.08
- Carlos F. Fernandez-del Castillo · 1 shared paper, 2019 · strength 0.08
- Jin Choi · 1 shared paper, 2019 · strength 0.08
- David P. Ryan · 1 shared paper, 2019 · strength 0.08
- Cristina Rosa Ferrone · 1 shared paper, 2019 · strength 0.08
- Gabriel A. Brooks · 1 shared paper, 2014 · strength 0.06
- Yun Wang · 1 shared paper, 2014 · strength 0.06
- Douglas Adam Rubinson · 1 shared paper, 2014 · strength 0.03
- Harvey J. Mamon · 1 shared paper, 2014 · strength 0.03
- Kimmie Ng · 1 shared paper, 2014 · strength 0.03
- Alec C. Kimmelman · 1 shared paper, 2014 · strength 0.03
- James M. Cleary · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.